W
ith respect to closure of atrial septal defects (ASDs), there is a saying that large ASDs need to be closed because they are large and small ASDs need to be closed because they are small. The saying was the fruit of percutaneous device closure. When open heart surgery was the only option, the indication bar was set relatively high at a shunt index expressed as Q p /Q s >1. 5 . This meant that the pulmonary blood flow volume per minute had to be >50% higher than the systemic. Smaller shunts were by no means acquitted from enlarging the right ventricle and both atria or from allowing paradoxical embolism, but their respective risks were deemed not to justify the perils of open heart surgery. Now, this indication threshold has become an oxymoron. There is the possibility to close a small ASD in an outpatient procedure with just local anesthesia of the groin in <30 min and send the patient back a few hours later to a completely normal life including sports.
In this issue of JACC: Cardiovascular Interventions, a Japanese group lay to rest another possible contraindication for percutaneous ASD closure, namely, old age (1). Looking at 3 age groups (50 to 59 years, 60 to 74 years, and $75 years), they confirm that even in the oldest age group, percutaneous ASD closure was safe and beneficial. Although the oldest age group had a higher mortality than the younger ones, this was unrelated to the ASD or its closure. Exercise capacity, heart failure markers, and echocardiographic parameters were significantly improved in all age groups examined. The average hospital stay was more than 3 days, but this was likely more due to Japanese customs than to the age of the patients or the treatment applied.
The problem of atrial fibrillation (AF) remains.
Somewhat surprisingly, the prevalence of permanent AF was only 17%, i.e., 3% in the youngest, 14% in the middle, and 42% in the oldest age group. The ex- 
